pular para conteúdo
Prescription drugs Ver prévia deste item
FecharVer prévia deste item
Checando...

Prescription drugs

Autor: Sylvia Engdahl
Editora: Detroit : Greenhaven Press/Gale Cengage Learning, ©2008.
Séries: Current controversies.
Edição/Formato   Livro : InglêsVer todas as edições e formatos
Base de Dados:WorldCat
Classificação:

(ainda não classificado) 0 com críticas - Seja o primeiro.

Assuntos
Mais como este

 

Encontrar uma cópia na biblioteca

&AllPage.SpinnerRetrieving; Encontrando bibliotecas que possuem este item...

Detalhes

Formato Físico Adicional: Online version:
Prescription drugs.
Detroit : Greenhaven Press/Gale Cengage Learning, c2008
(OCoLC)768252756
Tipo de Material: Recurso Internet
Tipo de Documento: Livro, Recurso Internet
Todos os Autores / Contribuintes: Sylvia Engdahl
ISBN: 9780737739626 0737739622 9780737739633 0737739630
Número OCLC: 192079717
Descrição: 246 p. ; 24 cm.
Conteúdos: Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir --
Some prescription drugs on the market are unsafe / Consumer reports --
Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher --
Post-marketing study of prescription drugs is not adequate / David J. Graham --
No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb --
Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine --
Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller --
Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross --
Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere --
Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados --
Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels --
Drug promotion plays on people's fears of future illness / Barbara Mintzes --
Drug promotion has led to the overmedication of children / Anne Taylor Fleming --
No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds --
Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer --
Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony. Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --
Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider --
Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett --
New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello --
No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber --
Medical innovation would stop if the government controlled drug prices / Sidney Taurel --
Controlling drug prices would reduce access to medicine / Doug Bandow --
Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari --
Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick --
Prescription drugs are often abused / Nichole Aksamit --
Young people often trade prescription drugs with friends / Amy Harmon --
Teens use prescription drugs to get high / Donna Leinwand.
Título da Série: Current controversies.
Responsabilidade: Sylvia Engdahl, book editor.
Mais informações:

Críticas

Críticas contribuídas por usuários
Recuperando críticas GoodReas...
Recuperando comentários DOGObooks

Etiquetas

Seja o primeiro.

Ítens Similares

Assuntos Relacionados:(3)

Listas de usuários com este item (2)

Confirmar esta solicitação

Você já pode ter solicitado este item. Por favor, selecione Ok se gostaria de proceder com esta solicitação de qualquer forma.

Dados Ligados


<http://www.worldcat.org/oclc/192079717>
library:oclcnum"192079717"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/192079717>
rdf:typeschema:Book
schema:about
<http://id.worldcat.org/fast/1060129>
rdf:typeschema:Intangible
schema:name"Pharmaceutical industry"@en
schema:name"Pharmaceutical industry."@en
schema:about
<http://id.worldcat.org/fast/1060194>
rdf:typeschema:Intangible
schema:name"Pharmaceutical policy"@en
schema:name"Pharmaceutical policy."@en
schema:about
schema:about
schema:about
schema:about
<http://id.worldcat.org/fast/898888>
rdf:typeschema:Intangible
schema:name"Drugs--Public opinion"@en
schema:name"Drugs--Public opinion."@en
schema:about
schema:about
schema:contributor
schema:copyrightYear"2008"
schema:datePublished"2008"
schema:exampleOfWork<http://worldcat.org/entity/work/id/119960281>
schema:inLanguage"en"
schema:name"Prescription drugs"@en
schema:numberOfPages"246"
schema:publisher
schema:url
schema:workExample
schema:workExample

Content-negotiable representations

Close Window

Por favor, conecte-se ao WorldCat 

Não tem uma conta? Você pode facilmente criar uma conta gratuita.